68 a. La Short-Term Persistence Substudy (STPS), p.68 ,
78 a, p.80 ,
Sadzot-Delvaux «Le virus de la varicelle et du zona dans le système nerveux : retraite silencieuse ou guérilla permanente ?» Virologie n°4, pp.207-216, 2000. ,
Molecular mechanisms of varicella zoster virus pathogenesis, Nature Reviews Microbiology, vol.86, issue.3, pp.197-210, 2014. ,
DOI : 10.1038/nrmicro3215
«Varicelle de l'enfant» chez EMC Pédiatrie/Maladies infectieuses, pp.4-310, 2006. ,
Canada. www.santepublique.gc.ca. Virus varicelle zona fiche technique santé-sécurité : agents pathogènes ,
«Item 84 -Infections à herpès virus de l'enfant et de l'adulte immunocompétents : varicelle et zona» chez Annales de dermatologie et de vénérologie, 2008. ,
«VZV : molecular basis of persistence (latency and reactivation)» chez Human Herpesviruses : Biology, Therapy, and immunoprophylaxis, 2007. ,
Hôpital Jean Verdier, «fmp-usmba,» http://www.fmpusmba.ac.ma/umvf/UMVFmiroir/campus-numeriques/campus- pediatrie ,
«La varicelle» Cahier de la puericultrice n°249, pp.31-34, 2011. ,
«VZV T cell-mediated immunity» chez Varicella-Zoster Virus : Current Topics in Microbiology and immunology, pp.341-358, 2010. ,
https://www.mesvaccins.net/web/news/5629- nouvelles-recommandations-vaccinales-de-l-organisation-mondiale-de-la-sante-contre-lavaricelle-et-le-zona ,
Conseil supérieur d'hygiène publique de France (section des maladies transmissibles) relatif à la vaccination contre la varicelle, pp.127-156, 2004. ,
Herpes Zoster and Human Immunodeficiency Virus Infection, Journal of Infectious Diseases, vol.166, issue.5, pp.1153-1156, 1992. ,
DOI : 10.1093/infdis/166.5.1153
Selective Impairment of Lymphocyte Reactivity to Varicella-Zoster Virus Antigen among Untreated Patients with Lymphoma, Journal of Infectious Diseases, vol.137, issue.5, pp.531-540, 1978. ,
DOI : 10.1093/infdis/137.5.531
Relationship between Preexisting Anti-Varicella-Zoster Virus (VZV) Antibody and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients, Journal of Clinical Microbiology, vol.44, issue.12, pp.41-43, 2006. ,
DOI : 10.1128/JCM.01312-06
Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants, New England Journal of Medicine, vol.347, issue.1, pp.26-34, 2002. ,
DOI : 10.1056/NEJMoa013441
The nature of herpes zoster: a long-term study and a new hypothesis», Proc R Soc Med, vol.58, pp.9-20, 1965. ,
Varicella???Zoster Virus???Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine, The Journal of Infectious Diseases, vol.200, issue.7, pp.1068-1077, 2009. ,
DOI : 10.1086/605611
Lymphocyte responses to varicella zoster virus in the elderly, Journal of Clinical Immunology, vol.149, issue.2, pp.174-178, 1987. ,
DOI : 10.1007/BF00916011
Multiple latent viruses reactivate in astronauts during Space Shuttle missions, Brain, Behavior, and Immunity, vol.41, pp.210-217, 2014. ,
DOI : 10.1016/j.bbi.2014.05.014
Uchakin et al, «Fatigue in Medical Residents Leads to Reactivation of Herpes Virus Latency» Interdisciplinary Perspectives on Infectious Diseases, 2011. ,
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults, New England Journal of Medicine, vol.352, issue.22, pp.71-84, 2005. ,
DOI : 10.1056/NEJMoa051016
Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer, Current Opinion in Virology, vol.1, issue.4, pp.268-279, 2011. ,
DOI : 10.1016/j.coviro.2011.07.007
Similar herpes zoster incidence across Europe: results from a systematic literature review, BMC Infectious Diseases, vol.127, issue.68, 2013. ,
DOI : 10.1017/S0950268801005921
«Aging, Immunity, and the Varicella?Zoster Virus», N Engl J Med, issue.2, 2005. ,
«Le zona : diagnostic, évolution, modalités de prise en charge et vaccination» Repères en Gériatrie, p.124, 2013. ,
Herpes Zoster and Postherpetic Neuralgia in Older Adults, Clinics in Geriatric Medicine, vol.23, issue.3, pp.615-632, 2007. ,
DOI : 10.1016/j.cger.2007.03.003
«Natural history and treatment of herpes zoster», The Journal of Pain, vol.9, issue.1, pp.3-9, 2008. ,
Herpes virus, virus varicelle-zona (VZV), cytomégalovirus (CMV), mononucléose infectieuse, diphtérie» chez Neuropathies périphériques, polyneuropathies et mononeuropathies multiples, pp.203-211, 2005. ,
Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice, Pain, vol.153, issue.2, pp.342-349, 2012. ,
DOI : 10.1016/j.pain.2011.10.026
Le zona et ses complications neurologiques, Revue Neurologique, vol.162, issue.8-9, pp.879-887, 2006. ,
DOI : 10.1016/S0035-3787(06)75096-2
Le zona et ses complications douloureuses, constats et rapports d'experts, 2014. ,
«Incidence of herpes zoster ophtalmicus:results from the Pacific Ocular Inflammation Study» Ophthalmology, pp.451-456, 2013. ,
«Diaphragmatic paralysis following cervical herpes zoster», Med J Aust, vol.153, pp.555-556, 1990. ,
Management of herpes zoster (shingles) and postherpetic neuralgia, Expert Opinion on Pharmacotherapy, vol.0, issue.4, pp.551-559, 2004. ,
DOI : 10.1097/00002508-200009000-00005
«Increased risk of stroke after a herpes zoster attack. A populationbased follow-up study» Stroke, pp.3443-3451, 2009. ,
Herpes Zoster, New England Journal of Medicine, vol.347, issue.5, pp.340-346, 2002. ,
DOI : 10.1056/NEJMcp013211
«Recommendations for the Management of Herpes Zoster» Clinical Infectious Diseases, pp.1-26, 2007. ,
Proposed classification of herpes zoster pain, The Lancet, vol.343, issue.8913, p.1648, 1994. ,
DOI : 10.1016/S0140-6736(94)93106-2
Practical Consideration for Prevention and Treatment», Korean J Pain, vol.28, pp.3-177, 2015. ,
«Predictors of posthepetic neuralgia among patients with herpes zoster : a prospective study», The Journal of Pain, vol.3, issue.3, pp.1-11, 2010. ,
Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: Prospective prognostic study, Pain, vol.132, pp.52-59, 2007. ,
DOI : 10.1016/j.pain.2007.02.004
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory, The Journal of Pain, vol.5, issue.6, pp.344-356, 2004. ,
DOI : 10.1016/j.jpain.2004.06.001
Pain Questionnaire» chez Pain Measurement and Assessment, pp.41-47, 1983. ,
«Preliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1)» Rev Epidemiol Sante Publique, pp.371-379, 1995. ,
Aaronson NK et al «Cross-validation of item selection and scoringfor the SF-12 Health Survey in nine countries : results from the IQOLA Project InternationalQuality of, Life Assessment» J Clin Epidemiol, issue.11, pp.51-71, 1998. ,
Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire, Quality of Life Research, vol.40, issue.3, pp.169-180, 1993. ,
DOI : 10.1007/BF00435221
«The Hospital Anxiety and Depression Scale» Acta Psychiatr Scand, pp.361-370, 1983. ,
The Impact of Acute Herpes Zoster Pain and Discomfort on Functional Status and Quality of Life in Older Adults, The Clinical Journal of Pain, vol.23, issue.6, pp.490-496, 2007. ,
DOI : 10.1097/AJP.0b013e318065b6c9
Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life, Clinical Infectious Diseases, vol.39, issue.3, pp.342-348, 2004. ,
DOI : 10.1086/421942
Impact of herpes zoster and post-herpetic neuralgia on patients??? quality of life: a patient-reported outcomes survey, Journal of Public Health, vol.82, issue.Suppl 2, pp.367-374, 2010. ,
DOI : 10.1007/s10389-010-0323-0
URL : https://hal.archives-ouvertes.fr/hal-00535311
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study, Canadian Medical Association Journal, vol.182, issue.16, pp.1731-1737, 2010. ,
DOI : 10.1503/cmaj.091711
Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice, Pain, vol.153, issue.2, pp.342-349, 2012. ,
DOI : 10.1016/j.pain.2011.10.026
«Un traitement antiviral précoce ne prévient pas toutes les douleurs associées au zona» Médecine et maladies infectieuses, pp.461-466, 2013. ,
«Antiviral treatment for preventing postherpetic neuralgia» Cochrane database Syst Rev, 2009. ,
Ferahta, «Recommandations pour le traitement et la prévention du zona et des douleurs associées chez la personne âgée» Rev Med Interne, 2015. ,
«A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster» Neurology, pp.444-447, 2005. ,
«Effect of a single dose of pregabalin on herpes zoster pain» Trials, p.55, 2011. ,
«Systematic Review and meta-analysis of efficacy, safety and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia» Ann Pharmacother, pp.1483-90, 2011. ,
Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies, Pain, vol.113, issue.3, pp.251-254, 2005. ,
DOI : 10.1016/j.pain.2004.10.007
«Douleurs zostériennes et post-zostériennes chez la personne âgée : analyse des évidences pour une prise en charge adaptée» Rev Med Suisse, pp.1374-1382, 2012. ,
et al «Gabapentin for chronic neuropathic pain and fibromyalgia in adults», Cochrane Database Syst Rev, issue.3, 2011. ,
Pregabalin for acute and chronic pain in adults, Cochrane Database Syst Rev, vol.17, issue.5, 2009. ,
DOI : 10.1002/14651858.CD007076.pub2
Efficacy and Tolerability of Gastric-retentive Gabapentin for the Treatment of Postherpetic Neuralgia, The Clinical Journal of Pain, vol.25, issue.3, pp.185-192, 2009. ,
DOI : 10.1097/AJP.0b013e3181934276
EFNS guidelines on pharmacological treatment of neuropathic pain, European Journal of Neurology, vol.32, issue.2, pp.1113-88, 2010. ,
DOI : 10.1053/eujp.2001.0316
«Topical capsaicin for chronic neuropathic pain in adults» Cochrane Database Syst Rev, 2009. ,
«Subcutaneous injection of botulinium toxin a is beneficial in postherpetic neuralgia», Clin Drug Investig, vol.11, pp.1827-1860, 2010. ,
«Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50?59 Years» Clinical Infectious Diseases, pp.922-928, 2012. ,
ansm.sante.fr/Activites/Surveillance-des- medicaments/Surveillance-des-medicaments ,
Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and Older, Journal of the American Geriatrics Society, vol.25, issue.10, pp.1499-1507, 2007. ,
DOI : 10.1111/j.1532-5415.2007.01397.x
Concomitant administration of zoster and pneumococcal vaccines in adults ???60 years old, Human Vaccines, vol.6, issue.11, 2008. ,
DOI : 10.4161/hv.6.11.12852
Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials, Clinical Therapeutics, vol.37, issue.11, pp.2388-2397, 2015. ,
DOI : 10.1016/j.clinthera.2015.09.019
Vaccination against Herpes Zoster and Postherpetic Neuralgia, The Journal of Infectious Diseases, vol.197, issue.s2, pp.228-236, 2008. ,
DOI : 10.1086/522159
«Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the ShortTerm Persistence Substudy» Clinical Infectious Diseases, pp.1320-1328, 2012. ,
«Long-term Persistence of Zoster Vaccine Efficacy» Clinical Infectious Diseases, pp.900-909, 2015. ,
«Safety of Zostavax?a cohort study in a managed care organization» Vaccine, pp.6636-6677, 2012. ,
«Evaluation de l'incidence du zona, de la proportion des douleurs postzostériennes , et des coûts associés dans la population française de 50 ans ou plus» Revue d'Epidémiologie et de Santé Publique, pp.393-401, 2010. ,
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination, PharmacoEconomics, vol.48, issue.6 Suppl., pp.125-136, 2013. ,
DOI : 10.1007/s40273-012-0020-7
Les vaccins contre le zona??: efficacit??, s??curit??, et rapport co??t/b??n??fices, La Presse M??dicale, vol.45, issue.2, 2015. ,
DOI : 10.1016/j.lpm.2015.10.015
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost???effectiveness analysis, Expert Review of Pharmacoeconomics & Outcomes Research, vol.13, issue.3, pp.393-406, 2013. ,
DOI : 10.1586/erp.13.19
«Cost effectiveness of herpes zoster vaccine in Canada» Pharmacoeconomics, pp.991-1004, 2009. ,
Effect of a Zoster Vaccine on Herpes Zoster-Related Interference with Functional Status and Health-Related Quality-of-Life Measures in Older Adults, Journal of the American Geriatrics Society, vol.58, issue.9, pp.1634-1641, 2010. ,
DOI : 10.1111/j.1532-5415.2010.03021.x
Vaccination contre le zona, Journal des Anti-infectieux, vol.17, issue.3, pp.115-119, 2015. ,
DOI : 10.1016/j.antinf.2015.07.004
Immune senescence and vaccines to prevent herpes zoster in older persons, Current Opinion in Immunology, vol.24, issue.4, pp.494-500, 2012. ,
DOI : 10.1016/j.coi.2012.06.002
«A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults» The Journal of Infectious Diseases, pp.1280-90, 2012. ,
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age, Journal of Infectious Diseases, vol.208, issue.12, pp.1953-61, 2013. ,
DOI : 10.1093/infdis/jit365
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults, New England Journal of Medicine, vol.372, issue.22, pp.2087-96, 2015. ,
DOI : 10.1056/NEJMoa1501184
«A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients» Blood, pp.2921-2929, 2014. ,
«Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo- Controlled Study» The Journal of Infectious Diseases, pp.1279-87, 2015. ,